Category: Editorial

December 29, 2021

The COVID-19 pandemic has demonstrated that it is essential for biopharmaceutical organizations to act quickly and become flexible in production.  Experts, such as the CHEManager International team, view four factors as unsolved challenges. They claim that the first challenge is […]

November 30, 2021

Almost two years have passed since the beginning of the COVID-19 pandemic that reshaped the world as we knew it. The virus responsible for the disease not only infected millions of people around the world, but also changed the way […]

October 29, 2021

As the COVID-19 pandemic continues to spread across the globe, many people are worried that the current vaccination may not be sufficient to curb the spread of the virus. While the successful development of effective vaccines has been one of […]

September 30, 2021

The COVID-19 pandemic has reshaped industries—especially healthcare and biopharma.  While vaccines provided governments and people in the US and abroad with a new way of fighting the virus, more help is needed. As a significant percentage of the population remains […]

August 30, 2021

The ongoing COVID-19 pandemic has sparked an unprecedented crisis for governments, healthcare providers, and industries across the world. Biopharmaceutical companies were especially affected, as they were left struggling to develop solutions that will ultimately help diagnose and treat those suffering […]

July 30, 2021

The Delta variant of the coronavirus has become the dominant strain around the world, bringing with it an increase in deaths in the US and many other countries. While the victims are almost exclusively unvaccinated, the new surge seems to […]

June 30, 2021

In 1982, the U.S. approved human insulin—the first ever recombinant biopharmaceutical drug. Since then, biopharma development has proceeded at an exponential pace, with new innovations redefining, over and over again, the possibilities of medicine.  Going forward, biopharma will demand more […]

May 28, 2021

With COVID-19 vaccines becoming more widely available around the world, and countries everywhere easing restrictions, a return to normal is now on everyone’s mind. While many activities are still recovering and regulations remain an important part of our daily lives, […]

April 30, 2021

Biopharmaceuticals are among the most complex and elegant realizations of modern science. But this complexity also comes at great cost. More exactly, biotech-manufacturing facilities need between $200 and $500 million to be built and this process could last up to […]